Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Precursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update.

Literature DB >> 25330822

Precursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update.

Felix Zeppernick¹, Ivo Meinhold-Heerlein, Ie-Ming Shih.

Abstract

Ovarian tumors comprise a wide variety of entities. The largest group, epithelial ovarian carcinoma, can be classified into two main groups, type I and type II tumors. Recent advances in the understanding of ovarian cancer development have resulted in the finding of 'serous tubal intraepithelial carcinoma', which is believed to represent the precursor lesion in high-grade serous ovarian carcinoma. In this review, lines of evidence for this are discussed and possible future implications for clinical and research settings are outlined.

Entities: Chemical Disease Gene Species

Keywords: epithelial ovarian cancer; fallopian tube; high-grade serous carcinoma; precursor; serous tubal intraepithelial carcinoma

Mesh：

Year: 2014 PMID： 25330822 PMCID： PMC4352308 DOI： 10.1111/jog.12550

Source DB: PubMed Journal: J Obstet Gynaecol Res ISSN： 1341-8076 Impact factor: 1.730

37 in total

1. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors: David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal: Am J Surg Pathol Date: 2007-02 Impact factor: 6.394

2. Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.

Authors: James R Conner; Emily Meserve; Ellen Pizer; Judy Garber; Michael Roh; Nicole Urban; Charles Drescher; Bradley J Quade; Michael Muto; Brooke E Howitt; Mark D Pearlman; Ross S Berkowitz; Neil Horowitz; Christopher P Crum; Colleen Feltmate
Journal: Gynecol Oncol Date: 2013-12-12 Impact factor: 5.482

3. The tubal hypothesis of ovarian cancer: caution needed.

Authors: Ian M Collins; Susan M Domchek; David G Huntsman; Gillian Mitchell
Journal: Lancet Oncol Date: 2011-08-23 Impact factor: 41.316

4. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.

Authors: C Bethan Powell; Lee-may Chen; Jane McLennan; Beth Crawford; Charles Zaloudek; Joseph T Rabban; Dan H Moore; John Ziegler
Journal: Int J Gynecol Cancer Date: 2011-07 Impact factor: 3.437

5. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.

Authors: B Modan; P Hartge; G Hirsh-Yechezkel; A Chetrit; F Lubin; U Beller; G Ben-Baruch; A Fishman; J Menczer; J P Struewing; M A Tucker; S Wacholder
Journal: N Engl J Med Date: 2001-07-26 Impact factor: 91.245

Review 6. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Authors: Robert J Kurman; Ie-Ming Shih
Journal: Hum Pathol Date: 2011-07 Impact factor: 3.466

7. Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.

Authors: Welmoed Reitsma; Geertruida H de Bock; Jan C Oosterwijk; Joost Bart; Harry Hollema; Marian J E Mourits
Journal: Eur J Cancer Date: 2012-08-21 Impact factor: 9.162

8. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.

Authors: Isaac Kinde; Chetan Bettegowda; Yuxuan Wang; Jian Wu; Nishant Agrawal; Ie-Ming Shih; Robert Kurman; Fanny Dao; Douglas A Levine; Robert Giuntoli; Richard Roden; James R Eshleman; Jesus Paula Carvalho; Suely Kazue Nagahashi Marie; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal: Sci Transl Med Date: 2013-01-09 Impact factor: 17.956

Review 9. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors: Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal: Lancet Oncol Date: 2012-05-09 Impact factor: 41.316

10. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

Authors: Britton Trabert; Roberta B Ness; Wei-Hsuan Lo-Ciganic; Megan A Murphy; Ellen L Goode; Elizabeth M Poole; Louise A Brinton; Penelope M Webb; Christina M Nagle; Susan J Jordan; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Galina Lurie; Susanne K Kjær; Estrid Hogdall; Allan Jensen; Daniel W Cramer; Kathryn L Terry; Allison Vitonis; Elisa V Bandera; Sara Olson; Melony G King; Urmila Chandran; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Anna H Wu; Celeste Leigh Pearce; Malcolm C Pike; Andrew Berchuck; Joellen M Schildkraut; Nicolas Wentzensen
Journal: J Natl Cancer Inst Date: 2014-02 Impact factor: 11.816

14 in total

1. New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination.

Authors: Lan G Coffman; Daniela Burgos-Ojeda; Rong Wu; Kathleen Cho; Shoumei Bai; Ronald J Buckanovich
Journal: Transl Res Date: 2016-03-30 Impact factor: 7.012

2. The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.

Authors: Hiroshi Kobayashi; Kana Iwai; Emiko Niiro; Sachiko Morioka; Yuki Yamada; Kenji Ogawa; Naoki Kawahara
Journal: Biomed Rep Date: 2017-07-27

3. Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium.

Authors: Jennifer Ose; Elizabeth M Poole; Helena Schock; Matti Lehtinen; Alan A Arslan; Anne Zeleniuch-Jacquotte; Kala Visvanathan; Kathy Helzlsouer; Julie E Buring; I-Min Lee; Anne Tjønneland; Laure Dossus; Antonia Trichopoulou; Giovanna Masala; N Charlotte Onland-Moret; Elisabete Weiderpass; Eric J Duell; Annika Idahl; Ruth C Travis; Sabina Rinaldi; Melissa A Merritt; Britton Trabert; Nicolas Wentzensen; Shelley S Tworoger; Rudolf Kaaks; Renée T Fortner
Journal: Cancer Res Date: 2017-04-05 Impact factor: 12.701

4. Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary.

Authors: Dmitriy W Gutkin; Michael R Shurin; Mounia Alaoui El Azher; Galina V Shurin; Liudmila Velikokhatnaya; Denise Prosser; Namhee Shin; Francesmary Modugno; Paul Stemmer; Esther Elishaev; Anna Lokshin
Journal: Cancer Biomark Date: 2019 Impact factor: 4.388

5. Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal Cancer.

Authors: I Meinhold-Heerlein; C Fotopoulou; P Harter; C Kurzeder; A Mustea; P Wimberger; S Hauptmann; J Sehouli
Journal: Geburtshilfe Frauenheilkd Date: 2015-10 Impact factor: 2.915